In this issue:
ECTRIMS/EAN consensus on vaccination in people with MS
Positive phase 3 results reported for twice-a-year subcutaneous ocrelizumab
Association between disability progression, relapses, and treatment in early relapse onset MS
Long-term trajectories of ambulatory impairment in MS
Blended versus face-to-face CBT for severe fatigue
Assessing everyday functional activity in cognitively impaired people with MS
The familial risk and heritability of MS and its onset phenotypes
Family planning and MS
MS Australia commits to a shared global research strategy to accelerate cures for MS
Is C. perfringens epsilon toxin associated with MS?
Inverse association between Mediterranean diet and risk of MS
New biomarker for early diagnosis of MS?
COVID-19 resources
Conferences, workshops, and CPD
Please login below to download this issue (PDF)